Development: Product-Specific Websites with FDA/EMA Promotional Compliance

Edenfuse — Full-Cycle Digital Agency for Life Sciences

Executive Summary: Your Product Website Is Now a Regulatory Instrument

In 2026, a pharmaceutical brand is not a marketing microsite — it is a regulated promotional instrument subject to active FDA surveillance, EMA advertising directives, and cross-border data privacy laws. The Office of Prescription Drug Promotion (OPDP) dramatically escalated enforcement in late 2025, issuing over 100 enforcement letters in a single month and deploying AI-powered surveillance tools to monitor digital promotional channels in real time. Meanwhile, the EU requires strict separation of promotional and non-promotional content, and GDPR governs every patient interaction.

At Edenfuse, we engineer brand platforms that transform regulatory constraint into competitive velocity. Our product-specific websites are built with MLR-native workflows, FDA-compliant content architecture, and EMA-aligned audience gating — so your medical, legal, and regulatory teams approve faster, your marketing teams launch sooner, and your patients engage safely.

The 2026 Market Reality:
– FDA OPDP now uses AI to proactively surveil drug ads across websites, social media, and influencer content
– MLR review demand has surged: biopharma companies are reviewing more content with the same resources, creating bottlenecks that delay launch timelines
– Optimized MLR workflows have demonstrated 57% reduction in review cycle times and 55% drop in time spent in review meetings
– Health tech development ranks among the highest-demand freelance skills globally with a 93/100 demand score
– Algorithmic content strategists — specialists who build compliant, scalable content systems — command $125–$275/hour with 49% projected growth through 2028
– AI-generated video and 3D mechanism-of-action visualization are now expected, not novel, in HCP engagement

If your brand cannot pass MLR review in 48 hours, cannot separate HCP and consumer content by jurisdiction, or cannot adapt to label updates in real time — you are not just losing market share. You are risking regulatory enforcement.

What This Service Delivers: Product-Specific Websites with Built-In Compliance

1. FDA/EMA Promotional Compliance Architecture

The Problem: FDA expects prescription drug websites to include risk information on the same screen as efficacy information, provide prominent links to prescribing information (PI), and ensure all claims are consistent with FDA-approved labeling (CFL). EMA requires that promotional content be clearly identifiable, not misleading, and accompanied by complete safety data. Most web agencies do not understand the difference between a “landing page” and a “promotional labeling operation.”

Edenfuse Solution:
– Dual-Audience Architecture: Separate but connected pathways for HCPs (promotional) and patients (disease awareness + branded), with jurisdictional gating for US vs. EU vs. RoW
– Fair Balance Engine: Automated layout systems that ensure risk information is visually and contextually proportional to benefit claims — meeting FDA’s “clear, conspicuous, and neutral” (CCN) standard
– Dynamic PI Linking: Prominent, persistent access to prescribing information, medication guides, and safety summaries — never buried behind clicks
– CFL Monitoring: Content management rules that flag any claim, image, or graphic deviating from FDA-approved labeling before publication
– Accelerated Approval Pre-Submission: For drugs under Accelerated Approval, built-in 30-day FDA pre-review workflows before any promotional material goes live
– Biosimilar Promotion Compliance: Specific content frameworks for reference biologic comparisons, consistent with FDA’s finalized biosimilar promotion guidance

2. MLR-Native Content Workflow

The Problem: The average MLR review cycle takes 14–21 days. In 2026, content volume is rising while review resources remain flat. Email-based approvals, shared PDFs, and generic project management tools create version chaos, audit gaps, and launch delays.

Edenfuse Solution:
– Veeva PromoMats Integration: Direct API connection to Veeva Vault for seamless document routing, redline annotations, and eCTD-compliant submission forms (FDA Form 2253)
– Tier-Based Review Automation: Content similarity scoring and tiered approval paths that reduce average time-to-approval by 50–75% for derivative materials
– MLR Bot-Ready Architecture: AI-assisted pre-review layer that flags red-flag phrases, boxed warning omissions, ISI inaccuracies, and accessibility violations before human review begins
– Multi-Document Campaign Workflows: Submit entire brand page sets, banner campaigns, and email sequences as unified MLR packages — not fragmented tickets
– Audit-Trail by Design: Every content version, approval signature, and regulatory submission is automatically archived with FDA 21 CFR Part 11-compliant electronic signatures
– Cross-Functional Dashboard: Real-time visibility for Medical, Legal, Regulatory, and Marketing teams into review status, bottlenecks, and compliance scores

3. HCP & Patient Engagement Platform

The Problem: HCPs now expect the same interactive, personalized digital experience from pharma brands that they receive from every other B2B platform. Patients expect clarity, empathy, and immediate access to support resources. Generic brochure-ware websites fail both audiences.

Edenfuse Solution:
– 3D Mechanism of Action (MoA) Visualization: Interactive scrollytelling and WebGL animations that explain how your therapy interacts with cellular targets — turning complex pharmacology into persuasive clinical narratives
– Interactive Dosing & Administration Guides: Step-by-step visual protocols for infusion, injection, or oral administration — optimized for tablet-based rep detailing and patient self-service
– Real-World Evidence (RWE) Data Modules: Explorable charts showing post-market outcomes, patient-reported data, and comparative effectiveness — all within promotional fair balance
– Patient Support Program Integration: Co-pay card portals, adherence tracking, and nurse navigator chat — with HIPAA/GDPR-compliant data handling
– HCP Sampling & e-Detailing: Connected to your CRM (Veeva, Salesforce Life Sciences Cloud) for closed-loop marketing
– Multi-Language Localization: Full i18n for EU markets with country-specific regulatory content variations (e.g., German AMG compliance, French AFSSAPS standards)

Technology Stack: Engineered for Promotional Velocity and Regulatory Certainty

Frontend & Experience Layer

Next.js 14+ / React: Server-side rendering for SEO, dynamic routing for multi-market content variants, and static generation for high-performance HCP portals
Three.js / WebGL: 3D molecular visualizations, interactive mechanism-of-action animations, and immersive product storytelling
Framer Motion: Cinematic page transitions and scroll-driven narratives that maintain HCP attention without compromising load performance
Tailwind CSS + Design Tokens: Atomic design system with pre-approved color palettes, typography scales, and component libraries — ensuring no off-brand or non-compliant visual elements enter production
Responsive-First Architecture: Full functionality across desktop (office-based HCPs), tablet (field rep detailing), and mobile (patient access)

Content & Compliance Layer

Headless CMS (Contentful / Sanity / Strapi): Decoupled content management with role-based editorial workflows — marketers update claims copy; medical teams control safety content; legal approves before publish
Veeva Vault API Integration: Bi-directional sync with PromoMats for MLR routing, version control, and regulatory submission automation
Content Similarity Engine: AI-powered duplicate detection and derivative content flagging to accelerate tier-based MLR reviews
Dynamic Content Gating: Geographic IP detection + HCP verification (via NPI/DEA lookup in US; HCP registration in EU) for audience-appropriate content delivery
Structured Data & Schema.org: JSON-LD markup optimized for AI discovery — ensuring your drug information appears accurately in ChatGPT, Gemini, and Perplexity responses when HCPs and patients ask clinical questions

Compliance & Security Layer

WCAG 2.1 AA/AAA Accessibility: Screen-reader optimization, high-contrast safety information, keyboard-navigable dosing calculators — because “in a field dedicated to improving human health, making your digital presence accessible to all humans is just good practice”
GDPR / ePrivacy Compliance: Granular cookie consent, data residency options (EU-hosted), and patient data minimization by design
FDA 21 CFR Part 11 Ready: Electronic signatures, audit trails, and document retention policies for promotional material submissions
SOC 2 Type II Hosting: AWS or Azure with healthcare-specific compliance configurations and dedicated security monitoring
Adverse Event (AE) Capture: Embedded reporting widgets that route suspected adverse events directly to your pharmacovigilance team — because promotional channels are AE intake points

Analytics & Optimization Layer

HCP Behavior Analytics: Anonymous session tracking to understand which clinical data points drive engagement, without violating Sunshine Act or GDPR
A/B Testing Framework: Compliant split-testing of headline claims, CTA placement, and MoA visualizations — with automatic MLR versioning of test variants
CRM Integration: Native connectors for Veeva Vault CRM, Salesforce Life Sciences Cloud, and IQVIA for closed-loop marketing attribution
Real-Time Performance Monitoring: Core Web Vitals, accessibility scoring, and SEO health dashboards

Segmented by Business Size: The Right Platform for Every Launch Stage

Small Pharma / Biotech / Single-Product Launch

Your Reality: You are preparing for your first commercial launch or pivotal Phase 3 readout. You have one asset, one indication, and zero tolerance for regulatory missteps. Your brand must establish clinical credibility, enable HCP education, and support patient access — all while your MLR team is still learning how to review digital content.

Edenfuse Launch Package:
– Single-Product Brand: HCP and patient pathways with built-in audience gating and jurisdictional routing
– Pre-Configured MLR Workflow: Veeva PromoMats-ready content structure with tier-1 review templates for rapid approval cycles
– 3D MoA Visualization: One interactive mechanism-of-action explainer to differentiate your science at congresses and in rep detailing
– Safety Content Framework: Pre-loaded ISI, boxed warning (if applicable), and PI linking architecture — reviewed by Edenfuse regulatory consultants
– Patient Support Gateway: Co-pay program enrollment, adherence resources, and nurse navigator contact — with GDPR/HIPAA-compliant data handling
– Congress-Ready Deployment: ASCO, ESMO, and JP Morgan launch timelines with pre-built event microsites
– Timeline: 8–10 weeks

Mid-Size Pharma / Multi-Product Portfolio

Your Reality: You manage 3–8 marketed products across multiple therapeutic areas. Each brand has its own MLR cycle, label updates, and market-specific requirements. Your websites have become a patchwork of legacy microsites with inconsistent compliance, fragmented analytics, and escalating maintenance costs.

Edenfuse Portfolio Package:
– Multi-Product Brand Hub: Unified design system with product-specific sub-sites, each maintaining independent MLR workflows and regulatory profiles
– Advanced MLR Automation: Veeva PromoMats integration with content similarity scoring, multi-document campaign workflows, and cross-product claim libraries
– Therapeutic Area Portals: Disease-state sections with educational content (non-promotional) seamlessly connected to branded product pathways
– Global Market Expansion: EU5 (DE, FR, ES, IT, UK) localization with EMA-compliant promotional separation and country-specific safety content
– HCP e-Detailing Suite: Interactive presentation mode for field reps with offline capability, sampling integration, and call logging to CRM
– RWE Data Integration: Post-market study results, patient-reported outcomes, and real-world evidence modules — all within fair balance
– Analytics Command Center: Cross-brand engagement dashboards showing HCP behavior, content performance, and MLR cycle efficiency
– Timeline: 12–16 weeks

Large Pharma / Global Enterprise / Franchise Management

Your Reality: You operate 20+ brands across dozens of markets, with a global MLR team processing thousands of promotional assets annually. Your digital ecosystem must support franchise-level consistency, market-level autonomy, and regulator-level audit readiness — while enabling innovation in AI-driven personalization and immersive HCP engagement.

Edenfuse Enterprise Package:
– Global Brand Ecosystem: Multi-tenant architecture supporting 50+ product sites with centralized governance and localized execution
– Enterprise MLR Orchestration: Full Veeva PromoMats integration with tier-based review, MLR Bot AI pre-review, automated FDA Form 2253 generation, and global approval routing
– Franchise Design System: Atomic component library with pre-approved claims, safety templates, and visual assets — empowering local markets to build compliant pages without central bottlenecks
– Advanced HCP Personalization: AI-driven content recommendation engines that serve relevant clinical data based on specialty, prescribing behavior, and engagement history — within governed privacy frameworks
– Immersive AR/VR Product Demos: Web-based augmented reality for HCP training, virtual injection demonstrations, and 3D anatomical explorations — the “next era of immersive engagement” that leading pharma brands are already deploying
– Global AE Integration: Unified adverse event capture across all brand properties with automated routing to pharmacovigilance systems
– Regulatory Intelligence Layer: Automated monitoring of FDA, EMA, and national health authority guidance changes with auto-flagging of affected brand content
– Timeline: 20–28 weeks

Customer Journey Map (CJM): From Brief to Live Brand

Phase 1: Regulatory & Brand Discovery (Weeks 1–2)

Stakeholder Alignment: Interviews with brand marketing, medical affairs, legal, regulatory, and market access teams to map approval authority and risk tolerance
Label & Claims Audit: Comprehensive review of FDA-approved labeling (PI), EMA SmPC, and any SIUU (Scientific Information on Unapproved Uses) protocols
Competitive Landscape Analysis: Review of competitor brand properties for compliance benchmarks, HCP engagement tactics, and innovation gaps
MLR Process Mapping: Documentation of current review workflows, bottleneck identification, and platform integration requirements (Veeva, Salesforce, etc.)
Jurisdictional Requirements: US (FDA OPDP), EU (EMA, national codes), UK (MHRA), and RoW regulatory mapping
Deliverable: Strategic creative brief, compliance architecture document, and MLR integration specification

Phase 2: Content Strategy & Information Architecture (Weeks 3–5)

Audience Segmentation: HCP personas (specialty, prescribing behavior, digital maturity) and patient personas (condition stage, health literacy, access needs)
Content Taxonomy: Promotional vs. non-promotional content classification, disease awareness vs. branded boundaries, and jurisdiction-specific content trees
MLR-Optimized Wireframing: Figma prototypes with embedded fair balance zones, PI link placements, and safety information hierarchies
3D MoA Storyboarding: Script and visual planning for mechanism-of-action animations and interactive clinical data visualizations
SEO & GEO Strategy: Keyword mapping for HCP search behavior, AI assistant visibility planning, and structured data architecture
Deliverable: Clickable prototype, content matrix with MLR routing tags, and technical specification

Phase 3: Design & Compliance Validation (Weeks 6–8)

Design System Development: Atomic component library with pre-approved colors, typography, and layouts that cannot violate brand or regulatory standards
Fair Balance Visual Testing: Eye-tracking simulation and readability testing to ensure risk information receives proportional visual weight
Accessibility Audit: WCAG 2.1 AA/AAA pre-validation with screen-reader testing and color contrast verification
HCP Usability Testing: Remote moderated testing with target specialists to validate navigation, clinical data comprehension, and engagement flow
MLR Workflow Configuration: Veeva PromoMats (or equivalent) setup with approval stages, user roles, and notification rules
Deliverable: Production-ready design system, validated prototypes, and configured MLR environment

Phase 4: Development & Integration (Weeks 9–14)

Frontend Development: Next.js/React build with component-based architecture and multi-market localization framework
CMS & Content Population: Headless CMS configuration with role-based editorial access and pre-loaded safety content templates
Veeva/CRM Integration: API connections for MLR routing, e-detailing, sampling, and adverse event capture
3D Animation & Interactive Modules: WebGL-based MoA visualizations, explorable clinical trial data, and interactive dosing guides
Security & Compliance Hardening: Penetration testing, GDPR audit, FDA 21 CFR Part 11 validation, and hosting compliance verification
Deliverable: Staging environment with full functionality and populated content

Phase 5: MLR Review & Regulatory Validation (Weeks 15–16)

Content Lock & MLR Submission: All promotional content routed through formal Medical-Legal-Regulatory review with tracked changes and annotation
FDA Form 2253 Preparation: Submission-ready documentation for promotional materials at time of first use
Label Consistency Verification: Final CFL (Consistent with Labeling) audit across all claims, visuals, and data presentations
Accelerated Approval Pre-Clearance: For applicable products, 30-day FDA pre-review coordination
Accessibility Certification: Final WCAG audit with remediation of any outstanding issues
Deliverable: MLR-approved content set, regulatory submission package, and compliance certification

Phase 6: Launch & Continuous Optimization (Week 17+)

Soft Launch: Limited release to internal teams, key opinion leaders (KOLs), and pilot HCP groups
Performance Monitoring: Core Web Vitals, HCP engagement analytics, MLR cycle time tracking, and SEO/GEO visibility scoring
AI Discovery Verification: Structured data testing for Google, Bing, ChatGPT, and Perplexity to ensure accurate clinical information representation
Congress & Campaign Support: Event-specific landing pages, banner ad synchronization, and email campaign integration
Training & Documentation: CMS training for brand teams, MLR workflow guides, and regulatory update protocols
Deliverable: Live brand, analytics dashboard, and 90-day optimization roadmap

Phase 7: Evolution & Expansion (Ongoing)

Label Update Response: Rapid content updates for FDA label changes, safety communications, and indication expansions
Market Expansion: Localization and regulatory adaptation for new geographic markets
Content Refresh: Quarterly MoA optimization, RWE data updates, and patient support program enhancements
MLR Process Optimization: Continuous refinement of review workflows based on cycle time data and team feedback
Technology Evolution: Integration of emerging capabilities (AI personalization, AR/VR, voice search) within governed frameworks
Annual Regulatory Audit: Comprehensive compliance review against updated FDA, EMA, and national authority guidance

What Business Problems This Service Solves

For Medical, Legal & Regulatory (MLR) Teams

Eliminates Review Bottlenecks: MLR-native architecture and Veeva integration reduce review cycles by up to 57%
Prevents Regulatory Enforcement: AI-powered pre-review and CFL monitoring flag OPDP-risky content before submission — critical as FDA now issues 70+ enforcement letters in single enforcement waves
Ensures Audit Readiness: Complete electronic audit trails, version histories, and FDA Form 2253 documentation are generated automatically
Supports Global Scale: Tiered review workflows and content similarity scoring enable small MLR teams to manage high-volume, multi-market content

For Brand Marketing & Commercial Teams

Accelerates Time-to-Launch: Pre-configured compliance templates and tier-based MLR paths get promotional content live faster than competitors
Enables Data-Driven Optimization: HCP engagement analytics show which clinical messages drive prescribing intent — without violating privacy regulations
Differentiates at Congresses: 3D MoA visualizations and interactive clinical data modules create memorable HCP experiences that static leave-behinds cannot match
Supports Omnichannel Strategy: Brand serves as the central content hub for rep detailing, email campaigns, social media, and paid media — ensuring message consistency

For Market Access & Patient Support

Improves Patient Adherence: Interactive dosing guides, adherence trackers, and co-pay program portals reduce barriers to treatment initiation and persistence
Enables GDPR-Compliant Engagement: Privacy-first architecture builds patient trust while capturing actionable adherence insights
Supports Value Demonstration: RWE modules and real-world outcome visualizations help payers and HTA bodies understand product differentiation
Captures Adverse Events: Embedded AE reporting ensures promotional channels contribute to pharmacovigilance compliance

For Leadership & Franchise Management

Reduces Compliance Risk: In 2026, a single OPDP warning letter can trigger DOJ investigation, stock price impact, and reputational damage. Prevention is cheaper than remediation.
Increases Commercial Agility: Modular architecture allows rapid response to label updates, competitive threats, and market opportunities
Optimizes Resource Allocation: Centralized design systems and automated MLR workflows reduce reliance on expensive external regulatory consultants
Future-Proofs Digital Investment: API-first architecture ensures your brand evolves with AI, AR/VR, and emerging engagement technologies without rebuild

2026 Market Analysis: The Compliance-First Digital Imperative

The Regulatory Enforcement Surge

2025 marked a watershed moment in pharmaceutical promotional oversight:
– FDA OPDP issued over 100 enforcement letters in September 2025 alone — a dramatic escalation from just 4 letters in 2022
– AI surveillance is now active: FDA uses automated tools to scan websites, social media, and influencer content for promotional violations
– DOJ False Claims Act enforcement remains aggressive, with individual executives and district managers increasingly facing personal liability for off-label promotion
– EMA and national EU codes are harmonizing digital advertising standards, with stricter requirements for promotional content identification and cross-border data flow

What this means: Promotional compliance is no longer a “check the box” exercise. It is a board-level risk management priority.

The Content Velocity Challenge

Biopharma content creation is accelerating while MLR resources remain constrained: – Drug approvals have risen sharply, increasing demand for launch content – AI-assisted content creation tools are enabling marketing teams to produce more assets faster — but MLR teams must review them all – Companies with optimized MLR workflows report 57% faster review cycles and 55% less meeting time – Those without optimization face launch delays, missed congress deadlines, and competitive disadvantage

The Talent & Freelance Market

Our analysis of 2026 market data reveals critical skill shortages in pharma digital compliance:
– Health Tech Development: 93/100 demand score, driven by telemedicine, patient portals, and HCP engagement platforms
– Algorithmic Content Strategists: $125–$275/hour, 49% growth through 2028 — specialists who build scalable, compliant content systems
– Veeva Vault Specialists: High demand, limited supply — particularly for PromoMats MLR configuration and Vault CRM migration
– AI Integration Specialists: 94/100 demand score, +1,847% growth — essential for MLR Bot deployment and AI-assisted compliance
– Regulatory Technology (RegTech) Developers: Shortage of developers who understand both FDA 21 CFR Part 11 and modern web architecture

What this means for you: Building an in-house team with this rare intersection of digital, regulatory, and pharma expertise takes 18–24 months. Edenfuse delivers it immediately.

The HCP Engagement Evolution

HCP expectations have permanently shifted:
– Omnichannel engagement is now baseline: HCPs expect seamless experiences across rep visits, email, webinars, and self-service portals
– 3D visualization and interactive data are becoming standard, not premium — “the next five years will bring a new era of immersive engagement”
– AI-driven personalization is emerging: predictive content recommendation based on specialty, prescribing behavior, and engagement history
– Community-driven platforms (Reddit, WhatsApp, private HCP networks) are overtaking traditional brand channels in trust and engagement

Companies that treat brand as a static brochure will lose HCP mindshare to competitors who treat it as a dynamic clinical resource.

Adjacent Services: Building Your 2030-Ready Commercial Ecosystem

Based on 2026 market trajectory and 5-year horizon analysis, Edenfuse recommends these integrated services to future-proof your pharmaceutical commercial infrastructure:

Immediate Complement (0–12 months)

Pharma SEO & GEO (Generative Engine Optimization): Structured data and authoritative content architecture so AI assistants accurately cite your clinical data when HCPs and patients ask treatment questions
Disease Awareness Microsites: Non-promotional educational platforms that build trust and capture early-stage patient/HCP interest — with clear regulatory boundaries from branded content
Congress & Event Digital Ecosystem: ASCO, ESMO, ADA, and JP Morgan microsites with embargo-ready content, KOL video libraries, and real-time engagement analytics
Email & CRM Automation: Veeva/Salesforce-integrated email campaigns with MLR-approved templates, automated personalization, and closed-loop attribution
Social Media Compliance Framework: Governed content systems for LinkedIn, YouTube, and emerging HCP community platforms with automated MLR routing

Growth-Stage Expansion (1–3 years)

AI-Powered MLR Pre-Review: Full deployment of LLM-based compliance bots that flag red-flag phrases, claim substantiation gaps, and fair balance violations before human review — reducing cycle times by 60–70% n- Predictive HCP Personalization: AI models that recommend next-best-content based on specialty, prescribing patterns, and engagement history — within governed privacy frameworks
AR/VR HCP Training Platform: Web-based augmented reality for virtual product demonstrations, injection technique training, and anatomical visualization — accessible without app downloads
Real-World Evidence (RWE) Publishing Platform: Automated integration of post-market study data, patient-reported outcomes, and registry feeds into brand clinical narrative modules
Digital Product Passport (DPP) for Pharma: GS1 Digital Link-enabled product traceability that connects physical drug packaging to dynamic safety, efficacy, and sustainability data
Voice Search & Conversational AI: Optimized content structures for Alexa, Google Assistant, and HCP voice queries — “the way people find information has fundamentally changed”

Strategic Horizon (3–5 years)

Autonomous Regulatory Monitoring: AI systems that continuously scan FDA, EMA, and national authority guidance updates, auto-flag affected brand content, and generate remediation recommendations
Blockchain-Verified Promotional Audit Trail: Immutable records of every content version, approval, and submission for regulator and DOJ audit defense
Quantum-Ready Molecular Simulation: Integration of quantum computing outputs into brand MoA visualizations for next-generation biologics and gene therapies
Pharma Metaverse Presence: Persistent virtual environments for HCP education, virtual advisory boards, and immersive patient support communities
Precision Patient Matching: AI-driven platforms that match patients to clinical trials, support programs, and financial assistance based on EHR-integrated eligibility criteria
Global Market Access Navigator: Integrated HTA submission trackers, pricing transparency tools, and reimbursement guidance across 50+ markets

Why Edenfuse? The Full-Cycle Compliance Advantage

We are not a creative agency that discovered pharma regulations last quarter. Edenfuse is built by professionals who have operated inside pharmaceutical commercial operations:

E-Commerce Managers who understand pharma-specific conversion paths — from HCP sampling to patient co-pay enrollment to specialty pharmacy fulfillment
Full-Stack Developers who have built Veeva-integrated platforms, FDA 21 CFR Part 11 validated systems, and HIPAA-compliant patient portals
Marketplace Specialists who navigate Amazon Pharmacy, GoodRx, and international distribution platforms for OTC and Rx products
Business Unit Leaders who align digital launches with quarterly earnings timelines, franchise P&L targets, and board-level risk management
Project Managers certified in pharma-agile methodologies that accommodate 6-month MLR review cycles and last-minute label changes
Data Analysts who transform CRM engagement data, RWE study results, and HCP behavioral signals into actionable commercial insights
Regulatory Consultants with direct experience in OPDP interactions, EMA scientific advice meetings, and national code compliance

Our Process Is Your Regulatory Shield: Every Edenfuse brand project includes: – Pre-launch MLR workflow validation with your Medical, Legal, and Regulatory teams – FDA Form 2253 readiness verification for all promotional materials – CFL (Consistent with Labeling) audit across every claim, image, and data point – WCAG accessibility certification with medical-use-case testing – Adverse event capture integration with your pharmacovigilance systems – Post-launch regulatory monitoring with quarterly compliance health checks

We do not launch until your MLR lead, Regulatory Affairs director, and Brand VP have signed off. And we do not disappear after launch — we evolve with your label, your markets, and your regulatory environment.

Call to Action: Your Next Step

For Single-Product Launches: Book a Pre-Launch Compliance Diagnostic — a 60-minute session where we audit your current promotional readiness, map your MLR workflow, and identify the fastest path to a compliant, compelling brand.

For Multi-Product Portfolios: Request a Portfolio Digital Audit — our team will analyze your existing brand ecosystem for compliance gaps, MLR inefficiencies, and competitive differentiation opportunities.

For Global Enterprises: Schedule an MLR Transformation Strategy Session — a deep-dive with our regulatory technology experts on how to reduce review cycle times by 50%+ while strengthening compliance posture.

Contact: – Website: www.edenfuse.com – Email: pharma@edenfuse.com – Calendar: calendly.com/edenfuse-brand-strategy

Edenfuse — Where Promotional Excellence Meets Regulatory Certainty.